CENTRICA PLC financials
CENTRICA PLC
E26EDV109X6EEPBKVH76 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Operating profit (EBIT) | £106.0M | £1.70B |
| Profit for the year | -£51.0M | £1.36B |
| Total comprehensive income | -£363.0M | £1.25B |
| Per share | ||
| Basic EPS | £-0.01 | £0.26 |
| Diluted EPS | £-0.01 | £0.25 |
| Free cash flow / share | £0.04 | £0.13 |
| Cash flow statement | ||
| Net cash from operating activities | £695.0M | £1.15B |
| Net cash from investing activities | -£690.0M | £493.0M |
| Purchase of PP&E (capex) | £554.0M | £416.0M |
| Net cash from financing activities | -£1.40B | -£1.55B |
| Proceeds from borrowings | £13.0M | £483.0M |
| Repayments of borrowings | £156.0M | £1.02B |
| Net change in cash | -£1.39B | £94.0M |
| Balance sheet | ||
| Total assets | £15.41B | £18.73B |
| Non-current assets | £4.91B | £4.59B |
| Property, plant & equipment | £1.49B | £1.86B |
| Intangible assets & goodwill | £504.0M | £478.0M |
| Current assets | £10.51B | £14.14B |
| Inventories | £339.0M | £904.0M |
| Trade & other receivables | £4.67B | £5.20B |
| Cash & equivalents | £4.31B | £6.34B |
| Total equity | £3.50B | £4.81B |
| — attributable to owners | £3.08B | £4.42B |
| Non-controlling interests | £411.0M | £390.0M |
| Non-current liabilities | £4.68B | £5.02B |
| Long-term borrowings | £2.62B | £2.66B |
| Current liabilities | £7.23B | £8.90B |
| Trade & other payables | £5.58B | £6.39B |
| Deferred tax liabilities | £2.0M | £88.0M |
| Derived metrics | ||
| Free cash flow | £141.0M | £733.0M |
| Return on equity | -1.5% | 28.4% |
| Cash conversion ratio | -13.63× | 0.84× |
| Capex coverage | 1.25× | 2.76× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | £546.0M | £164.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | £413.0M | £241.0M |
| Adjustments For Depreciation and Amortisation Expense | £428.0M | £473.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | £519.0M | £98.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -£150.0M | -£208.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | -£795.0M | -£657.0M |
| Adjustments For Provisions | -£129.0M | £110.0M |
| Adjustments For Sharebased Payments | £56.0M | £47.0M |
| Bank Overdrafts Classified As Cash Equivalents | £35.0M | £645.0M |
| Cancellation of Treasury Shares | £0 | £0 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | £4.27B | £5.69B |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £119.0M | £4.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | £960.0M | £2.06B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £22.0M | £92.0M |
| Comprehensive Income Attributable To Owners of Parent | -£384.0M | £1.21B |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | £10.27B | £14.14B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | £232.0M | £854.0M |
| Current Derivative Financial Assets | £600.0M | £1.31B |
| Current Derivative Financial Liabilities | £693.0M | £932.0M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | £7.06B | £8.90B |
| Current Provisions | £318.0M | £368.0M |
| Current Tax Assets | £90.0M | £70.0M |
| Current Tax Liabilities | £113.0M | £181.0M |
| Deferred Tax Assets | £659.0M | £339.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | £237.0M | £219.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | £0.04 | £0.03 |
| Dividends Received From Associates Classified As Investing Activities | £135.0M | £355.0M |
| Dividends Recognised As Distributions To Owners of Parent | £237.0M | £219.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -£29.0M | -£30.0M |
| Gains Losses On Exchange Differences On Translation Net of Tax | £24.0M | -£49.0M |
| Income Taxes Paid Refund Classified As Operating Activities | £375.0M | £636.0M |
| Increase Decrease Through Sharebased Payment Transactions | £54.0M | £33.0M |
| Insurance Contracts That Are Liabilities | £122.0M | £175.0M |
| Intangible Assets Other Than Goodwill | £318.0M | £318.0M |
| Interest Paid Classified As Financing Activities | £181.0M | £283.0M |
| Interest Paid Classified As Operating Activities | £16.0M | £16.0M |
| Interest Received Classified As Investing Activities | £227.0M | £317.0M |
| Investments In Subsidiaries Joint Ventures and Associates | £1.17B | £794.0M |
| Issued Capital | £313.0M | £344.0M |
| Liabilities | £11.92B | £13.92B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | £175.0M | £0 |
| Net Assets Liabilities | £3.50B | £4.81B |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | £238.0M | £0 |
| Noncurrent Derivative Financial Assets | £276.0M | £267.0M |
| Noncurrent Derivative Financial Liabilities | £343.0M | £455.0M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | £121.0M | £87.0M |
| Noncurrent Payables | £138.0M | £175.0M |
| Noncurrent Provisions | £1.27B | £1.49B |
| Noncurrent Receivables | £254.0M | £179.0M |
| Noncurrent Recognised Assets Defined Benefit Plan | £12.0M | £129.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | £307.0M | £150.0M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | £13.0M | £19.0M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | £57.0M | £400.0M |
| Other Comprehensive Income | -£312.0M | -£120.0M |
| Other Comprehensive Income Attributable To Noncontrolling Interests | £21.0M | £34.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -£5.0M | £2.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Hedging Instruments That Hedge Investments In Equity Instruments | -£5.0M | -£27.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -£324.0M | -£84.0M |
| Other Reserves | -£2.60B | -£2.29B |
| Payments To Acquire Or Redeem Entitys Shares | £9.0M | £8.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | £12.0M | £0 |
| Purchase of Interests In Investments Accounted For Using Equity Method | £42.0M | £56.0M |
| Retained Earnings | £2.98B | £3.98B |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | -£8.0M | £0 |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | £4.0M | £38.0M |
| Share Premium | £2.39B | £2.39B |
Every line item above is a fact tagged in CENTRICA PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.